Re:How an Alzheimer’s ‘cabal’ thwarted progress toward a cure
by bsder on Monday December 30, 2019 @03:54AM
(#21911865)
> The truth has a habit of shining through if you are encouraged to keep asking questions and follow up on them.
I would say that the latest Alzheimer's drug failure finally broke the camel's back. While NIH will tolerate groupthink indefinitely, biopharma eventually wants a payback.
I suspect biopharma pulling funding and causing the amyloid people to suddenly lose clout is more to blame for the come-to-Jesus party in Alzheimer's land.
I would say that the latest Alzheimer's drug failure finally broke the camel's back. While NIH will tolerate groupthink indefinitely, biopharma eventually wants a payback.
I suspect biopharma pulling funding and causing the amyloid people to suddenly lose clout is more to blame for the come-to-Jesus party in Alzheimer's land.